Intrinsiqs

Is aTyr Pharma, Inc. overvalued?

aTyr Pharma, Inc. (ATYR) — key valuation metrics and fundamentals.

No verdict
Price
$6.00
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$14.7M
Dividend yield
0.0%
Return on equity
-102.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ATYR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.